Skip to content
  • Home
  • Health & Tech
  • FDA & EMA
  • Oncology
  • Contact

Pharminent

FDA proposes smaller 2026 budget with more user fees than 2025

 June 2, 2025

FDA Commissioner Marty Makary is calling on Congress to fill the agency’s coffers next year with 4% less than 2025, including an 11% reduction in taxpayer funds but 4% more industry user fees. The fiscal …

Post navigation

Bispecific competition, debating oral SERDs and a bold GLP-1 prediction →
← Kymera, with new data, takes early step toward a Dupixent-like pill

RSS News – European Pharmaceutical Review

  • European Council announces progress on pharmaceutical package adoption June 4, 2025
  • BioNTech and BMS partner to advance oncology deal worth over $10 billion June 3, 2025
  • R&D and tech innovation boosting biopharmaceutical market to 2030 June 2, 2025
  • Roche reports long-term capabilities of multiple sclerosis drug May 30, 2025
  • New technology could enhance CAR T therapy manufacture May 29, 2025
  • New Eli Lilly acquisition to progress potential next-generation pain treatment May 28, 2025

RSS Big Molecule Watch

  • Sandoz Launches PYZCHIVA® (Ustekinumab) Autoinjector in Europe June 4, 2025
  • Samsung Bioepis Secures Marketing Approval in Korea for its Biosimilar to Amgen’s Bone Cancer Drug Xgeva June 3, 2025
  • EMA Issues Positive CHMP Opinions for Fresenius Denosumab Biosimilars June 2, 2025
  • Celltrion, Samsung Bioepis, and Organon Receive Interchangeability Designations for Adalimumab Biosimilars June 2, 2025
  • FDA Approves Bio-Thera and Hikma’s Ustekinumab Biosimilar May 29, 2025

RSS Drug Channels

  • Pharmacist Salaries and Employment in 2024: Retail Employment Collapse Offset by Hospital Boom June 3, 2025
  • Three Ways GoodRx Is Helping Pharmacies Increase Profitability and Drive Innovation May 30, 2025
  • Drug Channels News Roundup, May 2025: MFN Controversy, Plan Sponsors ♥️ Rebates, PBM Profits, and Fun in Congress May 28, 2025
  • How the IRA’s Part B Coinsurance Inflation Adjustments Can Raise Seniors’ Drug Costs May 21, 2025
  • What’s Next for Retail Pharmacy: Data, Debate, and Disruption (NEW Live Video Webinar) May 20, 2025
  • Resetting the Walk-Away Price: How GoodRx Data Reveals New Realities of Prescription Abandonment May 16, 2025
  • How Large PBMs Make Money Today: A 2025 Drug Channels Update May 13, 2025

Sign Up to Receive Updates

Check your inbox or spam folder to confirm your subscription.

@ 2025 Pharminent. All rights reserved

Design by ThemesDNA.com